KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) FCF Margin (2017 - 2025)

Guardant Health's FCF Margin history spans 8 years, with the latest figure at 3.56% for Q4 2025.

  • For Q4 2025, FCF Margin rose 2226.0% year-over-year to 3.56%; the TTM value through Dec 2025 reached 19.23%, up 1374.0%, while the annual FY2025 figure was 19.23%, 1374.0% up from the prior year.
  • FCF Margin for Q4 2025 was 3.56% at Guardant Health, up from 17.26% in the prior quarter.
  • Across five years, FCF Margin topped out at 3.56% in Q4 2025 and bottomed at 99.95% in Q2 2022.
  • The 5-year median for FCF Margin is 54.65% (2023), against an average of 51.82%.
  • The largest annual shift saw FCF Margin crashed -10745bps in 2021 before it skyrocketed 4159bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 93.99% in 2021, then increased by 24bps to 71.03% in 2022, then rose by 25bps to 53.4% in 2023, then soared by 52bps to 25.82% in 2024, then soared by 86bps to 3.56% in 2025.
  • Per Business Quant, the three most recent readings for GH's FCF Margin are 3.56% (Q4 2025), 17.26% (Q3 2025), and 28.41% (Q2 2025).